NIH-funded research R01 grant

Role of CCR2+ immune cells in persistent Salmonella granulomas

Official title: Role of inflammatory monocytes and other CCR2+ cells in the granulomatous response to persistent Salmonella infection

Funded at State University New York Stony Brook · NIH-11449303 · Data updated 2026-11-12

A patient-facing summary of how a study will look at how specific immune cells help form and control granulomas in chronic Salmonella infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startJuly 31, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$722,227
NIH project number1R01AI192792-01A1
Project IDNIH-11449303 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with chronic Salmonella infection or related granulomatous conditions in which CCR2+ immune cells are likely involved.

Less likely to help

People without persistent granulomatous infections or without CCR2+ cell involvement may not directly benefit.

What this research studies

This project studies how inflammatory monocytes and other CCR2+ immune cells contribute to the formation and maintenance of granulomas during long-lasting Salmonella infections. Researchers will study these cells in living systems to understand how they organize immune responses and antimicrobial activity within granulomas. The goal is to uncover mechanisms that balance protection against infection with potential tissue damage, which could guide new therapies for granulomatous diseases. The work may involve animal models and techniques that examine immune cell behavior in real time to link cellular actions to granuloma structure and function.

Why it matters

Potential benefit: If successful, the findings could lead to new approaches to treat chronic granulomatous infections and related inflammatory diseases.

How similar studies have gone: Similar studies have shown that CCR2+ cells influence granuloma dynamics in infections, though the exact mechanisms are still being defined.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Van Der Velden, Adrianus Wilhelmus Maria — State University New York Stony Brook
  • Study coordinator: Van Der Velden, Adrianus Wilhelmus Maria

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.